EMA New Human MedicinesOriginal article
Human medicines European public assessment report (EPAR): Sepalna, senaparib, Status: Opinion
RegulatorySepalnaNeutral
AI Analysis
Summary
The EMA's human medicines EPAR page for Sepalna (senaparib) lists its status as 'Opinion'. The article provides no details on the opinion's direction, indication, or sponsor.
Outcome Details
EMA EPAR status listed as 'Opinion' for Sepalna (senaparib); the article does not specify whether the opinion is positive or negative.
Importance:5/10
Sentiment:
0.00
EMAEPARsenaparibSepalnaregulatory opinionEurope
Read the original article
Published by EMA New Human Medicines on September 18, 2026 10:05 AM